Sorry I should have clarified. Vericel uses autologous Chondrocyte stem cells - they can literally only become cartilage stem cells. I have had Tenocyte stem cells (a decade ago) in a poorly surgically repaired tendon from the same Aussie company that developed the stem cell aspect of the MACI technology in knee OA - I will refrain from cross promoting stocks (but another Australian innovative company going unnoticed).
I actually believe that a far more more fit for purpose. Mesenchymals are too often a one size fits all remedy. Handy for PAR investors to get this, the same virtue of Mesenchymal stem cells flexible (multipotent stem cells that can become differnt stem cell types, including bone, cartilage cells, tendon and muscle and fat cells) arguably make them less efficient in efficacy and method of action. Logicially would you want 10,000,000 cartilage stem cells in your OA afflicted knee, or 10,000,000 adipose stem cells, some of which may become cartilage cells?
The future competition for me obviously comes more from chondrocyte cells, which literally can't become anything else. Hence I had Tenocyte stem cells for my bicep tendon, whereas a shoulder labrum injury was a cartilage/tendon mix and I (and my Specialist) felt Mesenchymals the right choice there.
I am a two time, well researched, stem cell receipient and advocate, but still (recntly) invested in PAR again. Speaks volumes.
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-4098
-
- There are more pages in this discussion • 299 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.95M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 35924 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 0.235 |
1 | 4761 | 0.225 |
9 | 76901 | 0.220 |
7 | 93958 | 0.215 |
5 | 131050 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 35958 | 3 |
0.240 | 22000 | 1 |
0.245 | 37318 | 1 |
0.250 | 55833 | 2 |
0.255 | 9785 | 1 |
Last trade - 09.51am 15/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online